THE ANTIRETROVIRAL DRUG RILPIVIRINE DIMINISHES IP-10/CXCL10 EXPRESSION: RELEVANCE IN THE CONTEXT OF LIVER DISEASE
Aleksandra Gruevska 1
Ángela Beatriz Moragrega 1
Federico Lucantoni 1
Joan Tosca 2
Juan V. Esplugues 2
Ana Blas-García 3
Nadezda Apostolova 3
1 Universidad de Valencia, Valencia, Spain
2 Hospital Clinic Universitari de Valencia, Valencia, Spain
3 FISABIO (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana), Valencia, Spain
Session
Liver & biliary (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]